Subscribe

Hass (450330.KQ)

KRW4,480.00 +20.00 (+0.45%)
KR KOE Healthcare Medical - Specialties
Address 77-14, Gwahakdanji-ro
Gangneung-si, KR
CEO Yong-Soo Kim
IPO 2024-07-01
ISIN KR7450330006

Explore sections of this company profile

Description

HASS Corp. specializes in the development and production of materials used for dental restoration. Its product lineup features Rosetta SM, Amber Mill, and Zirtooth. Founded on January 4, 2008, the company maintains its corporate headquarters in Gangneung, South Korea.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
KRW4,480.00 +20.00 (+0.45%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
59.0K
Beta
0.11
Float Shares
2.69M
Free Float %
34.3%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-2.48% -8.39% -17.37% -15.47% -14.37% -8.53% -29.43% -63.13% -63.13% -63.13% -63.13%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
4,480.00
Quality scores
Altman Z-Score
4.00
Safe zone
Piotroski F-Score
8 / 9
Strong
MOAT Score
2 / 10
No MOAT
Composite Rating
B
Overall Score
3 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
  • Revenue growth Medical - Specialties: +8.3%
    +2.6% Q1'26: -0.5% (vs Q1'25)
  • EPS growth Medical - Specialties: +10.1%
    -23.1% Q1'26: -18.4% (vs Q1'25)
  • FCF margin FCF growth · Medical - Specialties: +51.3%
    -17.4% Q1'26: -19.5% (vs Q1'25)
  • EBIT margin Medical - Specialties: +12.6%
    -7.7% Q1'26: -30.5% (vs Q1'25)
  • ROIC Medical - Specialties: +6.6%
    -3.8% Q1'26: -12.3% (vs Q1'25)
  • Share dilution Medical - Specialties: 0.0%
    +11.1% Q1'26: 0.0% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Medical - Specialties: -0.39×
    15.20× Q1'26: -3.00× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.25) × ERP
WACC = 88% × Ke + 12% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Current price: 4,480.00
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-29 B 3/5 1/5 3/5 4/5 3/5 1/5 4/5
2026-05-28 B 3/5 1/5 3/5 4/5 3/5 1/5 4/5
2026-05-27 B 3/5 1/5 3/5 4/5 3/5 1/5 4/5
2026-05-26 B 3/5 1/5 3/5 4/5 3/5 1/5 4/5
2026-05-22 B 3/5 1/5 3/5 4/5 3/5 1/5 4/5
2026-05-21 B- 3/5 1/5 3/5 4/5 2/5 1/5 4/5
2026-05-20 B- 3/5 1/5 3/5 4/5 2/5 1/5 4/5
2026-05-19 B- 3/5 1/5 3/5 4/5 2/5 1/5 4/5
2026-05-18 B- 3/5 1/5 3/5 4/5 2/5 1/5 4/5
2026-05-15 B 3/5 1/5 3/5 4/5 2/5 2/5 4/5
2026-05-14 B 3/5 1/5 3/5 4/5 2/5 2/5 4/5
2026-05-13 B 3/5 1/5 3/5 4/5 2/5 2/5 4/5
2026-05-12 B 3/5 1/5 3/5 4/5 2/5 2/5 4/5
2026-05-11 B 3/5 1/5 3/5 4/5 2/5 2/5 4/5
2026-05-08 B- 3/5 1/5 2/5 4/5 2/5 2/5 4/5
2026-05-07 B- 3/5 1/5 2/5 4/5 2/5 2/5 4/5
2026-05-06 B- 3/5 1/5 2/5 4/5 2/5 2/5 4/5
2026-05-04 B- 3/5 1/5 2/5 4/5 2/5 2/5 4/5
2026-04-30 B- 3/5 1/5 2/5 4/5 2/5 2/5 4/5
2026-04-29 B- 3/5 1/5 2/5 4/5 2/5 2/5 4/5
2026-04-28 B- 3/5 1/5 2/5 4/5 2/5 2/5 4/5
2026-04-27 B- 3/5 1/5 2/5 4/5 2/5 2/5 4/5
2026-04-24 B- 3/5 1/5 2/5 4/5 2/5 2/5 4/5
2026-04-23 B- 3/5 1/5 2/5 4/5 2/5 2/5 4/5
2026-04-22 B- 3/5 1/5 2/5 4/5 2/5 2/5 4/5
2026-04-21 B 3/5 1/5 2/5 5/5 2/5 2/5 4/5
2026-04-20 B 3/5 1/5 2/5 5/5 2/5 2/5 4/5
2026-04-17 B 3/5 1/5 2/5 5/5 2/5 2/5 4/5
2026-04-16 B 3/5 1/5 2/5 5/5 2/5 2/5 4/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
1.67B
OE per share TTM
349.25
Owner's Yield
3.61%
Maintenance CapEx ratio
Maint CapEx / Avg PPE
109.0%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
Total invested
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock

This company is not held by any ETF in our universe.

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives

Executive team data is not available for this company yet.

EBIT / Employee
-12.51M
Shares Outstanding
7.83M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

ESG Score History

No data available for this company.

Company data will be available after the next weekly refresh.
Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings reports

Stock splits